|
|
Volumn 9, Issue 5, 2007, Pages 342-343
|
|
Worksite treatment for cardiovascular disease prevention
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CHOLESTEROL;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ABSENTEEISM;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COMMUNITY CARE;
CORONARY ARTERY DISEASE;
COST BENEFIT ANALYSIS;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HEALTH ECONOMICS;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
KIDNEY FAILURE;
MORBIDITY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
RISK REDUCTION;
SMOKING CESSATION;
STROKE;
WORK ENVIRONMENT;
CARDIOVASCULAR DISEASES;
DELIVERY OF HEALTH CARE;
HUMANS;
OCCUPATIONAL HEALTH SERVICES;
WORKPLACE;
|
|
EID: 36849095960
PISSN: 15226417
EISSN: None
Source Type: Journal
DOI: 10.1007/s11906-007-0062-y Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
